loader2
Partner With Us NRI

Company details

214.45
229.90
170.20
289.55
6M Return 11.84%
1Y Return 12.90%
Mkt Cap.(Cr) 2,134.24
Volume 16,531
Div Yield 0.04%
OI
-
OI Chg %
-
Volume 16,531

Open Free Demat Account Online with ICICIDIRECT

SWOT

  • swot

  • technicals

  • deals

  • shareholding


EMA SMA

Delivery and volume

Financials

  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio

Sales(Cr.)

Operating Profit(Cr.)

Profit after Tax(Cr.)

Equity

Reserves and Surplus

Debt

Sales

Operating Profit

Profit after tax

PE

Debt/Equity

P BV

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 173.43 Cr FV: 1.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 30,916.98 -44,588.21
LAST 3M 79,590.49 -44,523.79
LAST 6M 143,408.31 -191,400.91
LAST 12M 204,102.65 -163,801.53

Information

  • About Company
  • Company Info
  • Listing Info
24.04
75.48%
23.5456
27.51%
29.22%
Description
  • Gufic Biosciences (GBL) is a result of a reverse merger of itself with Central Finance. The promoters of GBL took over Central Finance at Rs 40-42 per share and then got GBL listed on BSE. The Choksi and Gandhi family, the promoters of GBL, have a long-standing presence in the pharma industry. In 1960, the family set up a joint venture company called Lyka Labs. In 1976, they decided to part ways and the Choksi family took over the manufacturing facility and the Gufic group of companies was born. Initially known as Gujarat Fine Chemicals, the first foray of the Gufic group was in the manufacture of various bulk drugs. The company later entered the formulation market. Currently, the overall profile of GBL comprises ethical products, herbal products, consumer products and bulk drugs that are sold in the domestic and the international markets. Over the past several years, the company have a known reputation of creating brands that have vaulted to leadership positions in the category in which they have been marketed. To mention a few names: Shapers (sanitary napkins), Onergy, and Stretch nil. In the year 2000, the company issued Bonus Equity Shares in proportion of five Equity shares for every two Equity shares held. Gufic has divested brands in the ethical pharma business in a seller`s market. The company plan to invest further in R&D activities and aggressively enter the herbal product and consumer product segments, where it foresee a huge potential. While benefiting from the rich, traditional knowledge base in India, it would like to operate from an area of strength in the herbal products segment.

Read More

Registered Address

Shop-37 1st Flr Kamala Bhavan, Swami Nityanand Road Andheri(E, Mumbai, Maharashtra, 400069

Tel : 91-022-66919187/67261007/66919189
Email : info:guficbio.com
Website : http://www.guficbio.com

Registrar

Link Intime India Pvt Ltd

AGM Date (Month) : Nov
Face Value Equity Shares : 1
Market Lot Equity Shares : 1
BSE Code : 509079
NSE Code : GUFICBIO
Book Closure Date (Month) : Nov
BSE Group : B
ISIN : INE742B01025

ICICIdirect Gufic BioSciences Ltd FAQ

You can buy Gufic BioSciences Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Gufic BioSciences Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of May 16, 2022 04:01 PM the closing price of Gufic BioSciences Ltd was ₹ 220.15.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of May 16, 2022 04:01 PM, the market cap of Gufic BioSciences Ltd stood at ₹ 2,134.24.
The latest PE ratio of Gufic BioSciences Ltd as of May 16, 2022 04:01 PM is 24.04
The latest PB ratio of Gufic BioSciences Ltd as of May 16, 2022 04:01 PM is 0.11
The 52-week high of Gufic BioSciences Ltd is ₹ 289.55 while the 52-week low is ₹ 170.20 .

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote

CLOSE